For the Inventor, By the Inventor

Enter inventor name

Andrea Biffi

USPTO Granted Patents = 13 (Patent Applications = 19)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 19)

Average Co-Inventor Count = 1.7

ph-index = 3

Forward Citations = 11(Granted Patents)

Location History:

Milan, IT (2021 - 2023)
Urgnano, IT (2022 - 2024)
Trezzano Rosa, IT (2024)

Company Filing History:

Alfasigma S.p.a.

Lac2biome S.r.l.

Years Active: 2021-2025

Loading Chart...

Loading Chart...

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12447183 - Bacterial strains, their compositions and their use for the treatment of gastrointestinal disorders (2025-10-21),

2. 12036254 - Bacterial strains of thespecies for use, oral or topical, in the treatment of disorders of the female urogenital tract (2024-07-16),

3. 11896631 - Probiotics for use in the treatment of diverticulosis and diverticular disease (2024-02-13),

4. 11839634 - Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acid (2023-12-12),

5. 11752179 - Medical use of probiotics (2023-09-12),

6. 11751597 - Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems (2023-09-12),

7. 11690889 - Composition for use in the treatment of intestinal alterations (2023-07-04),

8. 11591416 - Exopolysaccharides and uses thereof (2023-02-28),

9. 11534468 - Composition based on probiotics and uses thereof (2022-12-27),

10. 11464814 - Topical composition for use in the treatment of inflammatory bowel disease (2022-10-11),

11. 11400124 - Use of probiotics for improving protein absorption (2022-08-02),

12. 11338002 - Use for treatment of clostridium difficile infections (2022-05-24),

13. 10881703 - Composition for use in the treatment of intestinal alterations (2021-01-05),

Title: Andrea Biffi: Innovator in Bacterial Strains and Gastrointestinal Treatments

Introduction

Andrea Biffi is a prominent inventor based in Urgnano, Italy, known for her significant contributions to the field of microbiology and gastrointestinal health. With a total of 13 patents to her name, she has made remarkable strides in developing bacterial strains and their applications in treating various disorders.

Latest Patents

Among her latest patents, Biffi has developed compositions that utilize specific bacterial strains for the treatment of gastrointestinal disorders. One notable patent describes a mixture comprising the bacterial strain MIMBb23sg or BbfIBS01 (DSM 32708), along with other selected strains, aimed at addressing functional gastrointestinal disorders such as irritable bowel syndrome (IBS). Additionally, she has created compositions for the treatment of disorders related to the female urogenital tract, focusing on restoring vaginal microbiota balance and alleviating associated symptoms.

Career Highlights

Throughout her career, Andrea Biffi has worked with notable companies such as Sofar S.p.a. and Alfasigma S.p.a. Her innovative work has positioned her as a leader in her field, contributing to advancements in health and wellness through her research and inventions.

Collaborations

Biffi has collaborated with esteemed colleagues, including Walter Fiore and Ruggero Rossi, to further her research and development efforts. These partnerships have enhanced her ability to innovate and bring her ideas to fruition.

Conclusion

Andrea Biffi's work in the field of bacterial strains and gastrointestinal treatments exemplifies her dedication to improving health outcomes. Her patents and collaborations reflect her commitment to advancing medical science and addressing critical health issues.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…